Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
The emergence of COVID-19 in March 2020 challenged Zimbabwe to respond with limited medical facilities and therapeutic options. Based on early clinical indications of efficacy for the macrocyclic lactone, Ivermectin (IVM), against COVID-19, IVM-based combination treatments were deployed to treat it....
Main Authors: | Jaqueline C. Stone, Pisirai Ndarukwa, David E. Scheim, Barry M. Dancis, Jerome Dancis, Martin G. Gill, Colleen Aldous |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biologics |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-8449/2/3/15 |
Similar Items
-
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
by: Stone, Jaqueline C., et al.
Published: (2022) -
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
by: Sabeena Ahmed, et al.
Published: (2021-02-01) -
Wheel Replacing Pyramid: Better Paradigm Representing Totality of Evidence-Based Medicine
by: Colleen Aldous, et al.
Published: (2024-02-01) -
1% ivermectin in combination therapy regimens for rosacea
by: E. A. Khlystova, et al.
Published: (2020-10-01) -
Spo2 Analysis on Development of IoT-Based Lung Function and Spo2 Measuring Device
by: Nadya Shavira, et al.
Published: (2024-02-01)